Evaluation of the efficacy and safety of topically applied cream on the properties of human stratum corneum.

Not Applicable

• Conditions: Healthy adult male

• Registration Number: JPRN-UMIN000048632
• Lead Sponsor: Otsuka Pharmaceutical Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-07-07
• Study Start: 2022-10-10
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 8

Inclusion Criteria

Not provided

Exclusion Criteria

- Subjects with chronic physical diseases such as diabetes, heart disease, kidney disease or liver dysfunction. - Subjects who have demonstrated a previous hypersensitivity reaction to any of the cosmetic products. - Subjects who have demonstrated a previous hypersensitivity reaction to adhesive tapes, medical tapes, or rubber. - Subjects with skin disease such as atopic dermatitis. - Subjects who have scars, nevus pimentosus, acne, erythema, or telangiectasia at the test sites. - Subjects who have undergone the plastic surgery at the test sites. - Subjects with excessively tanned skin at the test sites. - Subjects who have shaved, epilated, or removed hair from the test sites. for at least one month prior to obtaining consent. - Subjects who have topically applied drugs regularly at the test sites for at least one month prior to obtaining consent. - Subjects who have habitually washed their own skin with nylon or other solid materials for at least one month prior to obtaining consent. - Subjects who have undergone aesthetic plastic surgery such as peeling or laser irradiation at the test sites for at least six months prior to obtaining consent. - Subjects who are scheduled to receive vaccinations within the study period. - Subjects who are judged by doctor to be inappropriate for this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified